Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Craig LaFerriere"'
Autor:
Karen Green, Irene Martin, Mark Loeb, Jason LeBlanc, May ElSherif, Lingyun Ye, Donna MacKinnon-Cameron, Ardith Ambrose, Todd F Hatchette, Amanda LS Lang, Hayley D Gillis, Walter H Demczuk, Craig LaFerriere, Melissa K Andrew, Guy Boivin, William Bowie, Jennie Johnstone, Anne McCarthy, Allison McGeer, Makeda Semret, Sylvie Trottier, Louis Valiquette, Duncan Webster, Shelly A McNeil
Publikováno v:
BMJ Open Respiratory Research, Vol 7, Iss 1 (2020)
Background In Canada, 13-valent pneumococcal conjugate vaccine (PCV13) is recommended in childhood, in individuals at high risk of invasive pneumococcal disease (IPD) and in healthy adults aged ≥65 years for protection against vaccine-type IPD and
Externí odkaz:
https://doaj.org/article/89c02dc9740f4a5a8037a9d0017c7561
Autor:
Shelly A. McNeil, Nawab Qizilbash, Jian Ye, Sharon Gray, Giovanni Zanotti, Samantha Munson, Nathalie Dartois, Craig Laferriere
Publikováno v:
Canadian Respiratory Journal, Vol 2016 (2016)
Background. Routine vaccination against Streptococcus pneumoniae is recommended in Canada for infants, the elderly, and individuals with chronic comorbidity. National incidence and burden of all-cause and pneumococcal pneumonia in Canada (excluding Q
Externí odkaz:
https://doaj.org/article/2e811b93ed31434e826e0c8f829bc6cb
Autor:
Sylvie Trottier, Melissa K. Andrew, Makeda Semret, Amanda Ls Lang, Irene Martin, Shelly A. McNeil, Louis Valiquette, Jennie Johnstone, Ardith Ambrose, Karen Green, Walter Demczuk, Todd F. Hatchette, Mark Loeb, Donna MacKinnon-Cameron, Anne E. McCarthy, Jason J. LeBlanc, William R. Bowie, Lingyun Ye, May Elsherif, Allison McGeer, Hayley D. Gillis, Duncan Webster, Craig Laferriere, Guy Boivin
Publikováno v:
BMJ Open Respiratory Research, Vol 7, Iss 1 (2020)
BMJ Open Respiratory Research
BMJ Open Respiratory Research
BackgroundIn Canada, 13-valent pneumococcal conjugate vaccine (PCV13) is recommended in childhood, in individuals at high risk of invasive pneumococcal disease (IPD) and in healthy adults aged ≥65 years for protection against vaccine-type IPD and p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a5e42b9ac937341cc40667fa0dbd181
https://bmjopenrespres.bmj.com/content/7/1/e000550.full
https://bmjopenrespres.bmj.com/content/7/1/e000550.full
Autor:
John M McLaughlin, Luis Jodar, Bradford D Gessner, Craig Laferriere, Heather L Sings, Heinz-Josef Schmitt, Jose A Suaya, Raul E Isturiz, Philippe De Wals, Stephen I. Pelton
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
The 13-valent pneumococcal conjugate vaccine (PCV13) is the only licensed PCV with serotype 3 polysaccharide in its formulation. Postlicensure PCV13 effectiveness studies against serotype 3 invasive pneumococcal disease (IPD) in children have shown i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c60243766f6666adf59237d1eb3cc084
http://europepmc.org/articles/PMC6541704
http://europepmc.org/articles/PMC6541704
Autor:
Lizelle Gordon, Jean Petre, Craig Laferriere, Seanette Wilson, Jill Combrink, Neil Ravenscroft
Publikováno v:
Glycoconjugate Journal. 28:463-472
The introduction of type b Haemophilus influenzae conjugate vaccines into routine vaccination schedules has significantly reduced the burden of this disease; however, widespread use in developing countries is constrained by vaccine costs, and there i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0460d2e323337c89373ecc5f52631bb9
https://doi.org/10.1007/s10719-011-9344-3
https://doi.org/10.1007/s10719-011-9344-3
Autor:
Stephane B Dion, Craig Laferriere, Rajeev M. Nepal, Raul E Isturiz, Jelena Vojicic, Jose A Suaya, Maria Major, John M McLaughlin
Publikováno v:
Open Forum Infectious Diseases
Background In Canada, 13-valent pneumococcal conjugate vaccine (PCV13) was licensed for the prevention of vaccine-type (VT) pneumonia in adults in July 2015. Herd effects stemming from the routine pediatric PCV13 program have historically led to redu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1417d1e412a03e1cdaea99b073c6982
http://europepmc.org/articles/PMC6252882
http://europepmc.org/articles/PMC6252882
Autor:
Mark Atwood, Marie-Claude Breton, Reiko Sato, Derek Weycker, Linda Beausoleil, Craig Laferriere
Publikováno v:
Canadian Journal of Public Health
Objectives The Canadian National Advisory Committee on Immunization (NACI) recommends use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in a sequential schedule (PCV13 → PPV23) among adults aged ≥ 6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e913a3fff7408c64d32bb3cbf4ea34a
https://doi.org/10.1093/ofid/ofv133.1432
https://doi.org/10.1093/ofid/ofv133.1432
Publikováno v:
The Journal of Organic Chemistry. 60:4786-4797
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59ec8c33e046d8ea5ad1abdd108e98d3
https://doi.org/10.1021/jo00120a023
https://doi.org/10.1021/jo00120a023
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
A novel coronavirus SARS-CoV-2 causing Coronavirus disease 2019 (COVID-19) has entered the human population and has spread rapidly around the world in the first half of 2020 causing a global pandemic. The virus uses its spike glycoprotein receptor-bi
Externí odkaz:
https://doaj.org/article/e331ed48f34e4c7b8b740a04dd50bf20
Publikováno v:
Viruses, Vol 13, Iss 3, p 418 (2021)
The coronavirus SARS-CoV-2, which causes Coronavirus disease 2019 (COVID-19), has infected more than 100 million people globally and caused over 2.5 million deaths in just over one year since its discovery in Wuhan, China in December 2019. The pandem
Externí odkaz:
https://doaj.org/article/8b5b22061fc948038327e5117b1489bd